REGENXBIO (RGNX)

REGENXBIO (RGNX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• RGNX last traded at $7.20, -2.83% on the day.
• REGENXBIO: market cap $475.29M, P/E -1.9, revenue $174.48M over the last four quarters, next earnings 2026-11-05.
• Over the past year RGNX returned -43.84%; year to date -50.00%.

Updated 2026-11-02 19:09 UTC